RecruitingNCT05638724
Munich Long COVID Registry for Children, Adolescents, and Adults
Munich Long COVID Registry for Children, Adolescents, and Adults (MLC-R)
Sponsor
Technical University of Munich
Enrollment
1,000 participants
Start Date
Jul 20, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The MLC-R aims to create a large-scale registry that provides data on epidemiology, phenotypes, and disease trajectories of and health care for Long COVID at any age in Germany, which can be used for future clinical trials.
Eligibility
Inclusion Criteria3
- I. Written informed consent of the patient or legal guardian.
- II. Confirmed SARS-CoV-2 vaccination and/or confirmed or probable SARS-CoV-2 infection: Positive SARS-CoV-2 polymerase chain reaction (PCR) or rapid antigen test (AST), documented probable COVID-19 (e.g., typical CT scan), probable COVID-19 with a history of high-risk contact, anti-SARS-CoV-2-N antibodies (and/or in non-vaccinated people -S-IgG antibodies) following probable COVID-19.
- III. Additional ICD-10 codes: U09.9!V: Suspected post-COVID-19 condition, unspecified; U12.9!V: suspected adverse reactions to COVID-19 vaccine use, unspecified (post-COVIDvac condition).
Exclusion Criteria3
- Any subsequent medical data that question the diagnosis of PCC or post-COVIDvac condition
- Clinical picture can be explained by another underlying disease.
- Pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05638724